Healthcare M&A Advisory Pharmaceutical

M&A Advisory

Lazard

Full Credential Description

Hisamitsu Pharmaceutical Co., Inc.. Japan, United States. Announced Date 14/07/2009. Closed Date 27/08/2009. Deal value: $428m. Hisamitsu enters definitive merger agreement with Noven; Hisamitsu to commence tender offer for 100% of Noven shares. Industry: Hisamitsu Pharmaceutical Co., Inc. is primarily in the pharmaceutical industry, specializing in the development and production of transdermal patches and other topical medications.

Back to Search Contact Business